Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Erminia Ridolo, Francesco Pucciarini, Maria Cristina Nizi, Eleni Makri, Paola Kihlgren, Lorenzo Panella & Cristoforo Incorvaia. (2020) Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab. Human Vaccines & Immunotherapeutics 16:10, pages 2349-2356.
Read now
Read now
Articles from other publishers (11)
Zhiyu Chen, Fang Li, Lei Fu, Yu Xia, Ying Luo, Ang Guo, Xiaona Zhu, Huifang Zhong & Qian Luo. (2024) Role of inflammatory lipid and fatty acid metabolic abnormalities induced by plastic additives exposure in childhood asthma. Journal of Environmental Sciences 137, pages 172-180.
Crossref
Crossref
Shan Jing, Wenfang Liu, Kexu Yang, Yang Lin, Xuekun Yao & Guilan Sun. (2022)
The randomized, single‐ and multiple‐ ascending dose studies of the safety, tolerability, pharmacokinetics of
CSPCHA115
in healthy Chinese subjects
. Clinical and Translational Science 16:3, pages 447-458.
Crossref
Crossref
Louisa Hempel, Jakob Molnar, Andreas Gaumann, Sebastian Robert, Josef Scheiber, Axel Kleespies, Kristina Riedmann, Susanne Schreiber, Beate Gandorfer, Armin Piehler & Dirk Hempel. (2021) Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib. memo - Magazine of European Medical Oncology 14:4, pages 386-391.
Crossref
Crossref
Aida Paivandy & Gunnar Pejler. (2021) Novel Strategies to Target Mast Cells in Disease. Journal of Innate Immunity 13:3, pages 131-147.
Crossref
Crossref
Corrado Pelaia, Claudia Crimi, Alessandro Vatrella, Maria Teresa Busceti, Achille Gaudio, Eugenio Garofalo, Andrea Bruni, Rosa Terracciano & Girolamo Pelaia. (2020) New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant. Pharmacological Research 155, pages 104490.
Crossref
Crossref
Gaurav Agnihotri & Peter A. Lio. (2020) Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials. Clinical Drug Investigation 40:5, pages 421-431.
Crossref
Crossref
Marta de los Reyes Jiménez, Antonie Lechner, Francesca AlessandriniSina Bohnacker, Sonja SchindelaAurélien Trompette, Pascal HaimerlDominique Thomas, Fiona HenkelAndré Mourão, Arie GeerlofClarissa Prazeres da CostaAdam M. Chaker, Bernhard Brüne, Rolf NüsingPer-Johan Jakobsson, Wolfgang A. Nockher, Matthias J. Feige, Martin Haslbeck, Caspar OhnmachtBenjamin J. MarslandDavid Voehringer, Nicola L. Harris, Carsten B. Schmidt-WeberJulia Esser-von Bieren. (2020) An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products. Science Translational Medicine 12:540.
Crossref
Crossref
Kijeong Lee, Sang Hag Lee & Tae Hoon Kim. (2020) The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy. International Journal of Molecular Sciences 21:5, pages 1851.
Crossref
Crossref
Abdul R. Issahaku, Clement Agoni, Opeyemi S. Soremekun, Patrick A. Kubi, Ransford O. Kumi, Fisayo A. Olotu & Mahmoud E.S. Soliman. (2019) Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma. Combinatorial Chemistry & High Throughput Screening 22:8, pages 521-533.
Crossref
Crossref
Kareem Khalaf, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Fabrizio De Luca, Veronica Giorgis, Giorgio Walter Canonica & Enrico Heffler. (2019) Asthma from immune pathogenesis to precision medicine. Seminars in Immunology 46, pages 101294.
Crossref
Crossref
Orestes A. Carpaij, Janette K. Burgess, Huib A.M. Kerstjens, Martijn C. Nawijn & Maarten van den Berge. (2019) A review on the pathophysiology of asthma remission. Pharmacology & Therapeutics 201, pages 8-24.
Crossref
Crossref